Citation Impact
Citing Papers
Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells
2013 StandoutScienceNobel
Rodent-borne diseases and their risks for public health
2009 Standout
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
Induction of Mxi1-SRα by FOXO3a Contributes to Repression of Myc-Dependent Gene Expression
2007
Emerging Pharmacologic Approaches for the Treatment of Lower Urinary Tract Disorders
2004
The multifaceted roles of glycogen synthase kinase 3β in cellular signaling
2001 Standout
Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC Study
2006 Standout
The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society
2003 Standout
Function of the c-Myc Oncogenic Transcription Factor
1999
The Mad Side of the Max Network: Antagonizing the Function of Myc and More
2006
Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia
2006
The Epidemic of Antibiotic-Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America
2007 Standout
The neural control of micturition
2008 Standout
Immunohistochemical Distribution of cAMP- and cGMP-Phosphodiesterase (PDE) Isoenzymes in the Human Prostate
2006
Inflammatory Myofibroblastic Tumor
2007 Standout
EAU 2004 Guidelines on Assessment, Therapy and Follow-Up of Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction (BPH Guidelines)
2004
Efficacy and Tolerability of Fesoterodine in Men With Overactive Bladder: A Pooled Analysis of 2 Phase III Studies
2009
Urinary dysfunction in Parkinson's disease: A review
2008
Efficacy and Safety of Tadalafil Monotherapy for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: A Meta-Analysis
2013 Standout
Benign prostatic hyperplasia: age-related tissue-remodeling
2005
Proliferation, cell cycle and apoptosis in cancer
2001 StandoutNature
Effects of Serum PSA on Efficacy of Tolterodine Extended Release With or Without Tamsulosin in Men With LUTS, Including OAB
2008
Outcome measures for research in treatment of adult males with symptoms of lower urinary tract dysfunction
1998
An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunction
2009 Standout
Bladder outlet obstruction in women: Definition and characteristics
2000
A meta‐analysis comparing trials of antimuscarinic medications funded by industry or not
2006
Management of Overactive Bladder and Urge Urinary Incontinence in the Elderly Patient
2006
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
STATs in oncogenesis
2000 Standout
Effects of ??1-Adrenoceptor Antagonists on Male Sexual Function
2006
An overview on 5α-reductase inhibitors
2009
Molecular genetics of prostate cancer
2000
State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia
2004
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia
2002
Tumour-educated macrophages promote tumour progression and metastasis
2004 Standout
Reflecting on 25 years with MYC
2008 Standout
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
2013 Standout
P53 as a prognostic marker for bladder cancer: a meta-analysis and review
2005
Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis
2005 StandoutNature
The nitric oxide pathway in the human prostate: clinical implications in men with lower urinary tract symptoms
2008
Non-motor features of Parkinson disease
2017 Standout
M2mediated contractions of human bladder from organ donors is associated with an increase in urothelial muscarinic receptors
2006
Management of Overactive Bladder
2004
Efficacy and tolerability of tolterodine extended‐release in men with overactive bladder and urgency urinary incontinence
2006
Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review
2011
Transient Receptor Potential Cation Channels in Disease
2007 Standout
A review of the clinical efficacy and safety of 5α-reductase inhibitors for the enlarged prostate
2007
Design and Performance Evaluation of a Minimally Invasive Telerobotic Platform for Transurethral Surveillance and Intervention
2012
Prevalence and burden of overactive bladder in the United States
2003 Standout
An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction
2009 Standout
Industry sponsorship and research outcome
2012 Standout
Relationship between Schistosomiasis and Bladder Cancer
1999
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
The standardization of terminology in neurogenic lower urinary tract dysfunction with suggestions for diagnostic procedures
1999
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Continuum Robots for Medical Applications: A Survey
2015 Standout
Multidisciplinary management of a Jehovah’s Witness patient for the removal of a renal cell carcinoma extending into the right atrium
2002
Dissemination and publication of research findings: an updated review of related biases
2010 Standout
Is transurethral resection of the prostate still justified?
1999
The MAX-interacting transcription factor network
2006
Results of high-energy transurethral microwave thermotherapy in patients categorized according to the american society of anesthesiologists operative risk classification
1999
The extracellular matrix at a glance
2010 Standout
Proposal for a Urodynamic Redefinition of Detrusor Underactivity
2008
THE NATURAL HISTORY OF LOWER URINARY TRACT DYSFUNCTION IN MEN: MINIMUM 10-YEAR URODYNAMIC FOLLOWUP OF TRANSURETHRAL RESECTION OF PROSTATE FOR BLADDER OUTLET OBSTRUCTION
2005
The Max Network Gone Mad
2001
p53 Immunohistochemistry as a Prognostic Marker in Bladder Cancer
2000
Safety and Tolerability of Tolterodine for the Treatment of Overactive Bladder in Men With Bladder Outlet Obstruction
2006
Hoxb13is required for normal differentiation and secretory function of the ventral prostate
2003 StandoutNobel
The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children's Continence Society
2015 Standout
The Standardization of Terminology of Lower Urinary Tract Function in Children and Adolescents: Report from the Standardisation Committee of the International Children’s Continence Society
2006 Standout
Current and Future Pharmacological Treatment for Overactive Bladder
2002
Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten
2004 StandoutNobel
Good urodynamic practices: Uroflowmetry, filling cystometry, and pressure‐flow studies**
2002 Standout
Industry sponsorship and research outcome
2017 Standout
The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence Society
2002 Standout
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
The psychosocial impact of urinary incontinence in women
2011 Standout
Works of K. Höfner being referenced
The MXI1 tumor suppressor gene is not mutated in primary prostate cancer.
1998
Transurethral microwave thermotherapy: past, present and future
1994
Prognostic relevance of intracaval neoplastic extension for patients with renal cell cancer
1997
Alfuzosin: a clinically uroselective α1-blocker
2002
Symptomatic and quality of life response to tolterodine in subgroups of men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia
2009
Safety and efficacy of tolterodine extended release in men with overactive bladder symptoms and presumed non-obstructive benign prostatic hyperplasia
2007
Long‐term therapy with the dual 5α‐reductase inhibitor dutasteride is well tolerated in men with symptomatic benign prostatic hyperplasia
2005
p53 overexpression as a prognostic factor for advanced stage bladder cancer
1995
Efficacy and safety of two doses of tolterodine versus placebo in patients with detrusor overactivity and symptoms of frequency, urge incontinence, and urgency: urodynamic evaluation
1997
Future drugs for the treatment of benign prostatic hyperplasia
2002
Ultrasound measurement of detrusor wall thickness in healthy adults
2006
Age and Bladder Outlet Obstruction Are Independently Associated with Detrusor Overactivity in Patients with Benign Prostatic Hyperplasia
2008
Controlled, double-blind, multicentre clinical trial to investigate long-term tolerability and efficacy of trospium chloride in patients with detrusor instability
2003
Improvements in benign prostatic hyperplasia‐specific quality of life with dutasteride, the novel dual 5α‐reductase inhibitor
2003
Alfuzosin: a clinically uroselective alpha1-blocker.
2002
The International Continence Society “Benign Prostatic Hyperplasia” Study: International Differences in Lower Urinary Tract Symptoms and Related Bother
1997
Responders and Nonresponders to Transurethral Microwave Thermotherapy: A Multicenter Retrospective Analysis
1995
[Value of the proliferation status (PCNA) and p53 immunohistochemistry as a prognostic factor for the clinical course of superficial cancer of the urinary bladder].
1995
Effect of the dual 5 alpha-reductase inhibitor dutasteride on endocrine parameters and prostate volume
2002
Standardization of terminology of lower urinary tract function: Pressure-flow studies of voiding, urethral resistance, and urethral obstruction
1997
Tamsulosin 0.4 mg Once Daily: Tolerability in Older and Younger Patients with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction (Symptomatic BPH)
1997
Pressure-Flow Study Analyses in Patients Treated with High Energy Thermotherapy
1996